INSIGHTS ON DRUG DEVELOPMENT

• Cell Culture Automation Of The 3D Cancer Spheroid Assay

  Discover how automated 3D cell culture methods enhance efficiency and consistency in high-throughput drug screening to accelerate the discovery of new anti-cancer therapies.

• Leveraging Innovative Analytics To Ensure The Thermal Stability Of mAb Drug Products

  Uncover how innovative Rapid Screening-Differential Scanning Calorimeter technology is enabling robust analysis and regulatory compliance by ensuring the thermal stability of antibody drug products.

• Getting The Most Out Of Cell-Based Assays With The Optimal Read Function

  Gain insight into a whole-well fluorescence analysis that improves sensitivity and reproducibility in cell-based assays by accounting for uneven cell distribution.

• Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines

  Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.

• Navigating Complexity: Tailored Analytical & Preclinical Services

  2/26/2026

  Tailored analytical and preclinical strategies identify risk early, integrate data-driven insight, and streamline formulation planning to accelerate timelines and position complex molecules for scalable, successful development.

• Direct Amplification Of Samples Associated With Strawberry Leaf Punches

  6/9/2026

  Skip extraction and still achieve reliable qPCR results. See how direct amplification of plant samples enables faster workflows, lower costs, and clear detection of resistance markers.

• Why Emerging Drug Developers Can't Afford To Delay Analytical Development

  5/21/2026

  Rushing early pharma development by neglecting quality and analytical frameworks risks regulatory failures, clinical holds, and expensive rework.

• Five Practical Considerations To Move From Concept To Clinic

  12/17/2025

  Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.

• Fast And Scalable Fc Quantitation In Supernatants

  3/24/2025

  In biopharmaceutical development, the Fc PAIA Titer assay offers a fast, cost-effective, and automatable solution for high-throughput Fc quantification to enhance efficiency, support research, and accelerate production advancements.